Art. 8 Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 3×

In the case of authorised medicinal products which are protected either by a supplementary protection certificate under Regulation (EEC) No 1768/92, or by a patent which qualifies for the granting of the supplementary protection certificate, Article 7 of this Regulation shall apply to applications for authorisation of new indications, including paediatric indications, new pharmaceutical forms and new routes of administration.

For the purposes of the first subparagraph, the documents referred to in Article 7(1) shall cover both the existing and the new indications, pharmaceutical forms and routes of administration.

  • Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision

    Whilst, as stated above, the contested decision is based on the first of the interpretations of Article 11(1)(b) of Regulation No 1901/2006 envisaged in paragraph 52 above, the applicant argues in favour of the second of those …

    14 Dec 2011 · 62009TJ0052

  • Opinion of Mr Advocate General Bot delivered on 9 June 2011. Merck Sharp & Dohme Corp. v Deutsches Patent- und Markenamt.Decision

    Significantly, in my opinion, an examination of the scheme of Regulation No 1768/92 and the Medicines Regulation shows that the duration of the SPC is not one of the conditions for granting the six-month extension established by the …

    9 Jun 2011 · 62010CC0125

  • Judgment of the Court (Second Chamber) of 21 June 2018. Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH.Decision

    Article 36(1) of Regulation No 1901/2006 provides that, where an application under Article 7 or 8 of the regulation includes the results of all studies conducted in compliance with an agreed paediatric investigation plan, the holder of the …

    21 Jun 2018 · 62016CJ0681